The Lancet21h
The era of GLP-1 receptor agonists: costs versus benefits
Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and ...
GLP-1 meds might reduce blood clot risk in diabetes patients
People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their ...
Psychology Today3d
Can GLP-1 Agonists Treat Alcoholism?
GLP-1 drugs are quickly becoming some of the most ubiquitous in the U.S., and they have drawn interest for their potential ...
Medscape9d
ADA Advises Against Using Compounded GLP-1 RA Medications
In a new guidance statement, the American Diabetes Association advises against the use of unapproved products, warning of ...
JD Supra2d
Compounding and GLP-1s: What To Expect When GLP-1 Drugs Are Removed From FDA’s Drug Shortage List
What Are GLP-1s? Glucagon-like peptide-1 receptor agonists, also known as GLP-1 drugs, are a class of medications that mimic the action of ...
Medpage Today on MSN4d
GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots
Type 2 diabetes patients may have a lower risk of venous thromboembolism (VTE) when treated with a GLP-1 receptor agonist, ...
Experts Say GLP-1 Drugs Have Potential Use Beyond Weight Loss
Speaking at The New York Times’s DealBook Summit, Eli Lilly’s chief executive and an obesity medicine specialist discussed ...
healthday2d
GLP-1 Meds May Lower Clot Risk in People With Diabetes
People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions ...
Weight loss costs: Iowans struggle with insurance and access to ozempic, other GLP-1 drugs
Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...
Monthly Prescribing Reference6d
GLP-1 Receptor Agonist Use May Cut ESKD Risk in Lupus Nephritis
Glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment in patients with lupus nephritis may reduce the risk of progression to end-stage kidney disease (ESKD), according to a poster presentation ...
Weight loss drugs may also treat addiction, Alzheimer’s, and heart disease
But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...
The Irish News on MSN10d
GLP-1 receptor agonists also protect kidneys among patients with diabetes and obesity: Lancet
The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular ...